Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05905302Not ApplicableCompleted

The Impact of Exercise on Subthalamic Nucleus Neural Activity in Parkinson's Disease

Role: lead

NCT06442033Not ApplicableRecruiting

Genetics and Aerobic Exercise to Slow Parkinson's Disease Trial

Role: lead

NCT06418152Not ApplicableCompleted

Dual-task Augmented Reality for PD DBS

Role: lead

All 3 trials loaded